FDA DrugClass IINotable

FDA Recall: Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.

Date: 2026-04-22
Brand: Cipla USA, Inc.
Category: Drug
FDA Class: Class II

Description

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Hazard

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Remedy

113,336 bottles

View original recall →
Share:

Related Recalls

2026-04-22 · FDA_DRUG
FDA Recall: Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.
Cipla USA, Inc.
2026-04-22 · FDA_DRUG
FDA Recall: Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.
Cipla USA, Inc.
2026-04-15 · FDA_DRUG
FDA Recall: Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single
Cipla USA, Inc.
2026-04-15 · FDA_DRUG
FDA Recall: Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, M
Cipla USA, Inc.